Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „GoResp“
Suchtreffer
Begriffe & Kennungen
GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Concomitant use of other β adrenergic medicinal products and anticholinergic medicinal products can have a pot
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Concomitant use of other β adrenergic medicinal products and anticholinergic medicinal products can have a pot
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Hypokalaemia may increase the disposition towards arrhythmias in patients who are treated with digitalis glyco
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Hypokalaemia may increase the disposition towards arrhythmias in patients who are treated with digitalis glyco
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Hypokalaemia may result from β2-agonist therapy and may be potentiated by concomitant treatment with xanthine
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Hypokalaemia may result from β2-agonist therapy and may be potentiated by concomitant treatment with xanthine
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · In addition L-Dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards β2 sympathomimetics
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · In addition L-Dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards β2 sympathomimetics
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Paediatric population
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Paediatric population
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Pharmacodynamic interactions
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Pharmacodynamic interactions
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Pharmacokinetic interactions
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Pharmacokinetic interactions
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Potent inhibitors of CYP3A4 (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, teli
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · Potent inhibitors of CYP3A4 (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, teli
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · The potent CYP3A4 inhibitor ketoconazole, 200 mg once daily, increased plasma levels of concomitantly orally a
Eintrag öffnenGoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) · 4.5 · The potent CYP3A4 inhibitor ketoconazole, 200 mg once daily, increased plasma levels of concomitantly orally a
Eintrag öffnen